根据NCI泌尿生殖系恶性肿瘤科助理研究医师Melissa Abel博士所展示的数据，联合疗法显示PSA中位数下降40%，16名患者中有6名达到了超过50%的下降。无进展生存期范围为4.3至32.2个月。

新泽西州普林斯顿 - 临床阶段生物技术公司 PDS Biotechnology Corporation (NASDAQ:PDSB) ，市值约5100万美元，周四宣布美国专利局已为其领先的癌症免疫疗法资产PDS0101发出授权通知。

Canadian astronomers have taken an extraordinary step in understanding how planets are born, using the James Webb Space Telescope (JWST). JWST was used to study PDS 70, a young star with two growing ...

推荐 为解决传统U形分割网络难以捕捉复杂非线性特征以及跳跃连接存在特征信息损失的问题，研究人员开展了PDS - UKAN网络的研究。该网络通过创新模块提升了分割精度和可解释性。结果表明，PDS - UKAN在多个医学影像数据集上优于现有方法，对图像引导的医学 ...

PDS Biotech's Phase 2 study shows potential breakthrough in treating HPV16-positive head and neck cancer. The study shows a 87.1% 12-month survival rate for ICI naive patients, nearly doubling typical ...

Greetings. Welcome to PDS Biotech Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Mike Moyer ...